The OneFlorida Clinical Research Consortium Attends ASPO
In March, representatives of the OneFlorida Clinical Research Consortium attended the American Society of Preventative Oncology’s annual conference in Birmingham, Ala. Their goal was to raise awareness about the consortium’s endeavors among researchers and leaders in the field of cancer control and prevention from across the nation. The American Society of Preventive Oncology (ASPO) is a multi-disciplinary society that is committed to serving as an advocate for cancer prevention and control research. ASPO provides a variety of professional educational activities, designed to disseminate information about newly developed cancer prevention and control projects and implementation.
Katie Eddleton (left), Program Manager for the OneFlorida Clinical Research Consortium, and TaJuana Chisholm (right), Project Manager for the OneFlorida Cancer Control Alliance, attended the conference to bolster awareness about the consortium’s work, especially the OneFlorida Cancer Control Alliance. Conference attendees were informed about the role of the OneFlorida Cancer Control Alliance in enhancing the consortium’s structure and leading pragmatic clinical trials and implementation science studies in primary care settings in Florida.
“It was a great experience, and we gained additional knowledge about cancer prevention and control,” said Chisholm. “We were able to network with many researchers around the country.”
In addition, the expressed enthusiasm about the mission of the project and asked several questions about the consortium’s infrastructure and ability to support additional research studies, Chisholm said.
Learn more about ASPO here.